Condition: Cytomegalovirus Infections · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
The ReCySOHT study is a multicenter, retrospective, observational case-control study on the risk factors for developing a ganciclovir-resistant/refractory (GCV-RR) cytomegalovirus infection in patients receiving solid organ transplant (SOT) or hematopoietic stem cell transplant (HSCT). Aims of the study are to investigate the incidence of and risk factors for GCV-RR CMV infection in SOT recipients and HSCT patients in order to design further studies aimed at preventing and improving the patient management of GCV-RR CMV infections.
This description comes directly from the study's public registry record.
Renato Pascale, MD · +390512144350 · renato.pascale@aosp.bo.it
Maddalena Giannella, MD, PhD · +390512143199 · maddalena.giannella@unibo.it
Always discuss trial participation with your own doctor first.
| MD Anderson Cancer Center | Houston, Texas, United States | Not Yet Recruiting |
| Institut Jules Bordet | Brussels, Belgium | Not Yet Recruiting |
| University Hospitals Leuven | Leuven, Belgium | Not Yet Recruiting |
| Helsinki University Central Hospital | Helsinki, Helsinki, Finland | Not Yet Recruiting |
| Centre Hospitalier Universitaire de Limoges | Limoges, Limoges, France | Not Yet Recruiting |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna, Bologna, Italy | Recruiting |
| Humanitas Research Hospital | Rozzano, Milano, Italy | Not Yet Recruiting |
| Istituto mediterraneo per i trapianti e terapie ad alta specializzazione (ISMETT) | Palermo, Palermo, Italy | Recruiting |
| Ospedale San Martino | Genova, Italy | Not Yet Recruiting |
| Policlinico di Milano | Milan, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria di Modena | Modena, Italy | Recruiting |
| Azienda Ospedaliera dei Colli | Naples, Italy | Not Yet Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05234723